AstraZeneca will stop marketing its vaccine against Covid-19, Vaxzevria, starting tomorrow, Tuesday, in the European Union at your request. The British-Swedish company announced this in a statement.
The European Commission notified on March 27 that, at the request of the owner – AstraZeneca -, will withdraw the marketing authorization of the drug starting tomorrow. AstraZeneca justifies the withdrawal with the lack of demand and the surplus of vaccines currently available on the market.
“As numerous updated vaccines have been developed for Covid-19 variants, there is now a surplus of vaccines available. This has caused a decrease in demand for Vaxzervria, which is no longer being produced or supplied,” the statement read.
The laboratory, which submitted the withdrawal request on March 5 in Brussels, welcomes the role played by Vaxzevria in putting an end to the pandemic. In this sense he underlines that “according to independent estimates, in the first year of use alone, more than 6.5 million lives were saved and more than 3 billion doses were supplied worldwide”.